Literature DB >> 19922753

Pressor and tachycardic responses to intrathecal administration of neuropeptide FF in anesthetized rats.

Quan Fang1, Ning Li, Tian-nan Jiang, Qian Liu, Yu-lin Li, Rui Wang.   

Abstract

Neuropeptide FF (NPFF) belongs to a neuropeptide family including two precursors (pro-NPFF(A) and pro-NPFF(B)) and two receptors (NPFF(1) and NPFF(2)). NPFF and NPFF receptor mRNAs have been reported to be highly expressed and localized in the rat and human spinal cord. In the present study, the i.t. action of NPFF system on blood pressure and heart rate were examined using NPFF and two related agonists, NPVF and dNPA, which exhibit highest selectivities for NPFF(1) and NPFF(2) receptors, respectively. In urethane-anesthetized rats, NPFF and related peptides (5-40 nmol, i.t.) produced significant pressor and tachycardic responses at the spinal cord level. These effects were dose-dependent and similar with respect to time-course for the three peptides. Furthermore, i.t. injection of RF9 (20 nmol), a selective NPFF antagonist, significantly antagonized the cardiovascular responses to 20 nmol NPFF and related peptides (i.t.). Moreover, pretreatment of the rats with alpha-adrenoceptor antagonist phentolamine (1mg/kg, i.v.) significantly reduced the pressor effects of NPFF. Nevertheless, pretreatment with muscarinic receptor and adrenoceptor antagonists (i.v.) could block the tachycardic effects induced by NPFF. Collectively, our results suggested that i.t. administration of NPFF and related peptides increased MAP and HR which were possibly mediated by the activation of both NPFF(1) and NPFF(2) receptors in the rat spinal cord. In addition, our results showed that the muscarinic receptor and adrenoceptor participated in the tachycardic response to i.t. NPFF, while alpha-adrenoceptor played an important role in the regulation of pressor effect of NPFF. Copyright (c) 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19922753     DOI: 10.1016/j.peptides.2009.11.003

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  6 in total

1.  Neuropeptide FF-related gene in fish (Larimichthys polyactis): identification, characterization, and potential anti-inflammatory function.

Authors:  Ran Xiao; Zuting Guo; Li-Bing Zheng; Wei Huang; Chang-Feng Chi; Bao Lou
Journal:  Mol Biol Rep       Date:  2022-05-03       Impact factor: 2.742

2.  Intracerebroventricular Neuropeptide FF Diminishes the Number of Apneas and Cardiovascular Effects Produced by Opioid Receptors' Activation.

Authors:  Piotr Wojciechowski; Kryspin Andrzejewski; Katarzyna Kaczyńska
Journal:  Int J Mol Sci       Date:  2020-11-25       Impact factor: 5.923

3.  Role of neuropeptide FF in central cardiovascular and neuroendocrine regulation.

Authors:  Jack H Jhamandas; Valeri Goncharuk
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-07       Impact factor: 5.555

4.  In Vitro Activities of Kissorphin, a Novel Hexapeptide KiSS-1 Derivative, in Neuronal Cells.

Authors:  Nathaniel G N Milton
Journal:  J Amino Acids       Date:  2012-07-09

Review 5.  The Evolution and Variety of RFamide-Type Neuropeptides: Insights from Deuterostomian Invertebrates.

Authors:  Maurice R Elphick; Olivier Mirabeau
Journal:  Front Endocrinol (Lausanne)       Date:  2014-06-19       Impact factor: 5.555

6.  Lipidated PrRP31 metabolites are long acting dual GPR10 and NPFF2 receptor agonists with potent body weight lowering effect.

Authors:  Flora Alexopoulou; Esben Matzen Bech; Søren Ljungberg Pedersen; Ditte Dencker Thorbek; Ulrike Leurs; Lise Christine Biehl Rudkjær; Keld Fosgerau; Henrik H Hansen; Niels Vrang; Jacob Jelsing; Lisbeth Elster
Journal:  Sci Rep       Date:  2022-02-01       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.